Study Summary
This trial compares two techniques to see which is better at preventing collapsed lung during a robotic surgery.
Eligible Conditions
- Pulmonary
- Lung
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: through study completion; an average of 1 year.
Year 1
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Group 1
1 of 2
Group 2
1 of 2
Experimental Treatment
60 Total Participants · 2 Treatment Groups
Primary Treatment: Group 1 · No Placebo Group · N/A
Group 1
Procedure
Experimental Group · 1 Intervention: Ventilatory Strategy To Prevent Atelectasis · Intervention Types: ProcedureGroup 2
Procedure
Experimental Group · 1 Intervention: Lateral Decubitus Strategy (LADS) · Intervention Types: ProcedureTrial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion; an average of 1 year.
Who is running the clinical trial?
M.D. Anderson Cancer CenterLead Sponsor
2,827 Previous Clinical Trials
1,792,787 Total Patients Enrolled
Roberto Casal, MDPrincipal InvestigatorM.D. Anderson Cancer Center
2 Previous Clinical Trials
171 Total Patients Enrolled
Eligibility Criteria
Age 18+ · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is enrollment for this investigation still ongoing?
"Reportedly, according to the clinicaltrials.gov page, this trial is no longer recruiting patients. Initially posted on July 30th 2023 and last updated in January 26th 2023, there are 15 other trials that participants can contribute to instead." - Anonymous Online Contributor
Unverified Answer